Paid Clinical Trials Louisville

Discover 598 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 598

Study of LP-184 in Patients with Advanced Solid TumorsStudy of LP-184 in Patients with Advanced Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Lantern Pharma Inc.

Location:

Louisville KY, Indianapolis IN, Rolling Meadows IL, Springdale ARshow 5 more

Code:

NCT05933265

Conditions

Advanced Solid Tumor

Metastatic Solid Tumor

GBM

TNBC - Triple-Negative Breast Cancer

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LP-184

Spironolactone

Olaparib

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Louisville KY, Clarksville IN, New Albany IN, Cincinnati OHshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Louisville KY, Lexington KY, Cincinnati OH, Indianapolis INshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerA Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Iovance Biotherapeutics, Inc.

Location:

Louisville KY, Cincinnati OH, Pittsburgh PA, Milwaukee WIshow 6 more

Code:

NCT05361174

Conditions

Unresectable Melanoma

Metastatic Melanoma

Stage III Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

IOV-4001

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Louisville KY, Cincinnati OH, Indianapolis IN, Nashville TNshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

Louisville KY, Cleveland OH, Detroit MI, Pittsburgh PAshow 10 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling

Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- BowelPaclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

Recruiting

PHASE3

Sponsor:

GIE Medical

Location:

Louisville KY, Pittsburgh PA, Macon GA, Philadelphia PAshow 10 more

Code:

NCT05561127

Conditions

Bowel; Stricture

Eligibility Criteria

Sex: All

Age: 22+

Healthy Volunteers: Not accepted

Interventions

GIE Medical ProTractX3 TTS DCB

Control

Venetoclax and Lintuzumab-Ac225 in AML PatientsVenetoclax and Lintuzumab-Ac225 in AML Patients

Recruiting

PHASE1

PHASE2

Sponsor:

Actinium Pharmaceuticals

Location:

Louisville KY, New Orleans LA, New York NY, Los Angeles CAshow 1 more

Code:

NCT03867682

Conditions

Acute Myeloid Leukemia

Relapsed Adult AML

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lintuzumab-Ac225

Venetoclax

Spironolactone

Cortical Organization in Allogeneic Transplants or Heterotopic Hand ReplantsCortical Organization in Allogeneic Transplants or Heterotopic Hand Replants

Recruiting

Sponsor:

Christine M. Kleinert Institute for Hand and Microsurgery

Location:

Louisville KY

Code:

NCT01618682

Conditions

Hand Transplant

Hand Replant

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck CarcinomaSBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Recruiting

PHASE2

Sponsor:

RTOG Foundation, Inc.

Location:

Louisville KY, Cincinnati OH, Columbus OH, Saint Louis MOshow 15 more

Code:

NCT03546582

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Stereotactic Body Radiation Therapy (SBRT)